Hatfield S, Ruohola-Baker H: microRNA and stem cell function. Cell Tissue Res. 2008, 331 (1): 57-66.
Article
CAS
PubMed
Google Scholar
Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K: MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 2007, 67 (19): 8994-9000.
Article
CAS
PubMed
Google Scholar
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, et al: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007, 131 (6): 1109-1123.
Article
CAS
PubMed
Google Scholar
Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 2007, 6 (13): 1586-1593.
Article
CAS
PubMed
Google Scholar
Cho WC: OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007, 6 (1): 60-
Article
PubMed
PubMed Central
Google Scholar
Domen J, Gandy KL, Weissman IL: Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 1998, 91 (7): 2272-2282.
CAS
PubMed
Google Scholar
Domen J, Cheshier SH, Weissman IL: The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000, 191 (2): 253-264.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007, 26 (5): 745-752.
Article
CAS
PubMed
PubMed Central
Google Scholar
Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M: Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007, 26 (5): 731-743.
Article
CAS
PubMed
Google Scholar
Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al: p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007, 17 (15): 1298-1307.
Article
CAS
PubMed
Google Scholar
He X, He L, Hannon GJ: The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 2007, 67 (23): 11099-11101.
Article
CAS
PubMed
Google Scholar
He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA component of the p53 tumour suppressor network. Nature. 2007, 447 (7148): 1130-1134.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tazawa H, Tsuchiya N, Izumiya M, Nakagama H: Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA. 2007, 104 (39): 15472-15477.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS: Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004, 6 (6): R605-615.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q, Ji M, Pienta K, Lawrence T, Xu L: Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther. 2008, 7 (7): 2192-2202.
Article
CAS
PubMed
PubMed Central
Google Scholar
Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007, 67 (18): 8433-8438.
Article
CAS
PubMed
Google Scholar
Welch C, Chen Y, Stallings RL: MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007, 26 (34): 5017-5022.
Article
CAS
PubMed
Google Scholar
Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW: An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA. 2007, 104 (50): 19983-19988.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu L, Huang CC, Huang W, Tang WH, Rait A, Yin YZ, Cruz I, Xiang LM, Pirollo KF, Chang EH: Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther. 2002, 1 (5): 337-346.
CAS
PubMed
Google Scholar
Xu L, Frederik P, Pirollo KF, Tang WH, Rait A, Xiang LM, Huang W, Cruz I, Yin Y, Chang EH: Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum Gene Ther. 2002, 13 (3): 469-481.
Article
CAS
PubMed
Google Scholar
Xu L, Tang WH, Huang CC, Alexander W, Xiang LM, Pirollo KF, Rait A, Chang EH: Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med. 2001, 7 (10): 723-734.
CAS
PubMed
PubMed Central
Google Scholar
Xu L, Pirollo KF, Chang EH: Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release. 2001, 74 (1–3): 115-128.
Article
CAS
PubMed
Google Scholar
Xu L, Pirollo KF, Rait A, Murray AL, Chang EH: Systemic p53 Gene Therapy In Combination with Radiation Results in Human Tumor Regression. Tumor Targeting. 1999, 4: 92-104.
CAS
Google Scholar
Adams JM, Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007, 26 (9): 1324-1337.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zinkel S, Gross A, Yang E: BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 2006, 13 (8): 1351-1359.
Article
CAS
PubMed
Google Scholar
Phillips TM, McBride WH, Pajonk F: The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006, 98 (24): 1777-1785.
Article
PubMed
Google Scholar
Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006, 66 (12): 6063-6071.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005, 435 (7042): 677-681.
Article
CAS
PubMed
Google Scholar
Chao DT, Korsmeyer SJ: BCL-2 family: regulators of cell death. Annual Review of Immunology. 1998, 16: 395-419.
Article
CAS
PubMed
Google Scholar
Reed JC: Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Seminars in Hematology. 1997, 34 (4 Suppl 5): 9-19.
CAS
PubMed
Google Scholar
Reed JC: Double identity for proteins of the Bcl-2 family. Nature. 1997, 387 (6635): 773-776.
Article
CAS
PubMed
Google Scholar
Reed JC, Jurgensmeier JM, Matsuyama S: Bcl-2 family proteins and mitochondria. Biochimica et Biophysica Acta. 1998, 1366 (1–2): 127-137.
Article
CAS
PubMed
Google Scholar
Korsmeyer SJ: BCL-2 gene family and the regulation of programmed cell death. Cancer Research. 1999, 59 (7 Suppl): 1693s-1700s.
CAS
PubMed
Google Scholar
Han Z, Hong L, Han Y, Wu K, Han S, Shen H, Li C, Yao L, Qiao T, Fan D: Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax. J Exp Clin Cancer Res. 2007, 26 (2): 261-268.
CAS
PubMed
Google Scholar
DiPaola RS, Aisner J: Overcoming bcl-2- and p53-mediated resistance in prostate cancer. Seminars in Oncology. 1999, 26 (1 Suppl 2): 112-116.
CAS
PubMed
Google Scholar
Makin G, Dive C: Apoptosis and cancer chemotherapy. Trends in Cell Biology. 2001, 11 (11): S22-26.
Article
CAS
PubMed
Google Scholar
Reed JC: Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Advances in Pharmacology. 1997, 41: 501-532.
Article
CAS
PubMed
Google Scholar
Furuya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT: Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clinical Cancer Research. 1996, 2 (2): 389-398.
CAS
PubMed
Google Scholar
Catz SD, Johnson JL: BCL-2 in prostate cancer: a minireview. Apoptosis. 2003, 8 (1): 29-37.
Article
CAS
PubMed
Google Scholar
Bruckheimer EM, Brisbay S, Johnson DJ, Gingrich JR, Greenberg N, McDonnell TJ: Bcl-2 accelerates multistep prostate carcinogenesis in vivo. Oncogene. 2000, 19 (46): 5251-5258.
Article
CAS
PubMed
Google Scholar
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15 (3): 504-514.
Article
CAS
PubMed
Google Scholar
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al: ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell. 2007, 1 (5): 555-567.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007, 104 (3): 973-978.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67 (3): 1030-1037.
Article
CAS
PubMed
Google Scholar
Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK: Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA. 2006, 103 (30): 11154-11159.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wicha MS: Breast cancer stem cells: the other side of the story. Stem Cell Rev. 2007, 3 (2): 110-112. discussion 113
Article
PubMed
Google Scholar
Rich JN: Cancer stem cells in radiation resistance. Cancer Res. 2007, 67 (19): 8980-8984.
Article
CAS
PubMed
Google Scholar
Wicha MS: Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res. 2006, 12 (19): 5606-5607.
Article
PubMed
Google Scholar
Farnie G, Clarke RB: Breast stem cells and cancer. Ernst Schering Found Symp Proc. 2006, 5: 141-153.
PubMed
Google Scholar
Al-Hajj M: Cancer stem cells and oncology therapeutics. Curr Opin Oncol. 2007, 19 (1): 61-64.
PubMed
Google Scholar
Yang YC, Wang SW, Hung HY, Chang CC, Wu IC, Huang YL, Lin TM, Tsai JL, Chen A, Kuo FC, et al: Isolation and characterization of human gastric cell lines with stem cell phenotypes. J Gastroenterol Hepatol. 2007, 22 (9): 1460-1468.
Article
CAS
PubMed
Google Scholar
Katoh M: Dysregulation of stem cell signaling network due to germline mutation, SNP, helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther. 2007, 6 (6): 832-839.
Article
CAS
PubMed
Google Scholar
Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS: Stem cells in normal breast development and breast cancer. Cell Prolif. 2003, 36 (Suppl 1): 59-72.
Article
CAS
PubMed
Google Scholar